ERBB2 and breast carcinoma: Hormone status, evaluated through the expression of estrogen and progesterone receptors (ER and PR correspondingly), and the presence of human epidermal growth factor receptor 2 (HER2), play a major role for breast cancer molecular subtypes characterization and the election of therapeutic strategies (Zhang et al., 2014).